Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21702,785,0.96 [0.90-1.03],0.2764972368585543
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21701,127,0.86 [0.73-1.00],0.0553624706253992
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23073,134,1.08 [0.92-1.27],0.3415265127096502
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17199,439,0.94 [0.86-1.03],0.1579325676276172
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23019,80,1.00 [0.81-1.23],0.990261809173543
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22389,71,0.79 [0.64-0.98],0.02881688978324
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23903,79,1.01 [0.83-1.25],0.8936623886190034
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23924,53,0.98 [0.76-1.26],0.8812857820303385
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21913,40,1.15 [0.85-1.56],0.3601136167688398
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23466,96,0.87 [0.73-1.05],0.1426989097946611
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other septicaemia,23431,61,0.75 [0.60-0.93],0.010634740097668
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23961,57,1.12 [0.87-1.43],0.383652712373201
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other viral diseases,23925,90,1.04 [0.85-1.26],0.7234182866639927
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23917,82,1.04 [0.85-1.27],0.7251255976502673
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Mycoses,23764,45,1.08 [0.82-1.42],0.6007815932703608
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23204,334,0.90 [0.81-0.99],0.0288313845214717
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22991,121,0.89 [0.76-1.05],0.1703689306694985
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23088,218,0.91 [0.80-1.03],0.1181492937748876
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20763,28,0.87 [0.62-1.22],0.4298482468184129
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20778,43,0.99 [0.74-1.31],0.922774707325408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20848,113,1.09 [0.91-1.30],0.3379295375718302
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20853,118,1.09 [0.92-1.30],0.3289293231562716
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11660,258,0.93 [0.83-1.04],0.2133823207442536
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9354,21,1.61 [1.03-2.52],0.0380015047224376
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20778,43,0.95 [0.72-1.26],0.7447737269097423
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22139,703,0.99 [0.92-1.06],0.797847132075167
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23062,182,1.09 [0.95-1.25],0.2386672140928474
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23597,73,0.93 [0.75-1.14],0.4840679768167117
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24029,69,1.12 [0.89-1.40],0.327675507666295
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Rectum,23827,41,1.46 [1.07-1.99],0.0176802427895232
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24032,32,0.98 [0.71-1.35],0.8856715490117406
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Stomach,24067,25,1.06 [0.74-1.54],0.7410744609075832
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm,23800,261,0.96 [0.86-1.08],0.4986154443039008
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24008,104,0.91 [0.76-1.08],0.2884079183153627
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24012,80,1.00 [0.81-1.23],0.9943826200334026
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23982,40,0.83 [0.63-1.10],0.2006259781500857
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma, any site",23984,40,0.83 [0.63-1.10],0.2006048003344169
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi,23888,208,1.02 [0.90-1.16],0.787235047685111
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,24033,95,1.16 [0.95-1.40],0.1463561249763613
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Other benign neoplasms of skin,23947,162,1.03 [0.89-1.19],0.7284359878667233
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of breast,13272,81,1.00 [0.81-1.22],0.9755288755663204
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Leiomyoma of uterus,12968,608,1.02 [0.95-1.11],0.5466918512461727
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23201,169,1.06 [0.92-1.22],0.4243212269987088
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23102,303,0.98 [0.88-1.09],0.7607411786054357
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23102,303,0.98 [0.88-1.09],0.7607411786054357
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22025,307,0.93 [0.84-1.04],0.2003603059258578
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23641,68,0.89 [0.72-1.11],0.3194272302680312
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23848,88,0.98 [0.81-1.19],0.8357351640794064
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21093,611,1.04 [0.96-1.12],0.3130584999112089
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22959,376,1.03 [0.93-1.13],0.5840485821792308
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22484,92,0.93 [0.77-1.12],0.451084777518223
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Peripheral artery disease,23392,51,0.89 [0.70-1.15],0.3760769248250625
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22472,80,0.92 [0.75-1.13],0.4416659309132236
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22670,278,0.98 [0.87-1.10],0.7139812251027965
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22663,271,0.98 [0.87-1.10],0.7101275950374879
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22365,157,0.92 [0.78-1.07],0.2838784268495549
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22369,155,0.93 [0.79-1.08],0.3394824679953795
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20956,474,1.02 [0.93-1.11],0.6706186586267053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20545,63,0.89 [0.71-1.13],0.3436927440202229
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,20919,437,1.03 [0.94-1.12],0.5744935484428457
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20523,41,1.13 [0.84-1.53],0.4200054726915684
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20544,62,0.89 [0.71-1.13],0.3436017996125764
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Any mental disorder,20843,659,0.98 [0.91-1.05],0.5188727300080677
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20437,253,0.92 [0.81-1.03],0.144453303734441
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23689,190,0.90 [0.79-1.03],0.1214973049925279
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23744,137,0.91 [0.78-1.07],0.2590513073401944
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22339,68,0.77 [0.62-0.96],0.0173939248330625
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23970,68,0.77 [0.62-0.96],0.0177330203431859
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20252,68,0.77 [0.62-0.95],0.0149288780095061
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Alcohol dependence,22350,79,0.75 [0.61-0.92],0.0053876418605439
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Smoking dependency,22313,61,1.01 [0.79-1.29],0.9484838136328037
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20252,68,0.91 [0.73-1.13],0.4032971874531329
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20513,329,0.96 [0.87-1.06],0.4302736135991938
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Depression,22557,285,0.96 [0.86-1.07],0.4442375163484912
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Depression or dysthymia,20389,249,0.96 [0.85-1.08],0.4980861840330465
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20306,122,1.16 [0.97-1.37],0.1014727104985654
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Other anxiety disorders,22764,55,1.00 [0.78-1.28],0.9968750968677476
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Neurological diseases,21412,1273,1.00 [0.95-1.06],0.9920323821343924
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19940,151,0.95 [0.82-1.10],0.5022065025017619
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23878,123,0.99 [0.84-1.17],0.9056317474325788
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22914,427,1.00 [0.91-1.09],0.935048181025408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Epilepsy,22630,143,0.85 [0.73-0.98],0.0274520498628576
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Migraine,22573,86,1.07 [0.88-1.31],0.5060288170654074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23745,77,1.09 [0.88-1.35],0.4337073960465184
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Transient ischemic attack,23644,37,0.98 [0.73-1.33],0.9198169858430184
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other sleep disorders,22639,152,1.06 [0.91-1.23],0.4600537858388945
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Sleep apnoea,23531,116,1.06 [0.89-1.26],0.5030244125022549
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23075,535,1.02 [0.94-1.10],0.6481505497087507
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22664,124,1.03 [0.87-1.21],0.7604427697315874
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22828,288,1.00 [0.90-1.12],0.9440872997106426
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23877,76,1.10 [0.89-1.37],0.368875449036961
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hemiplegia,23850,49,1.03 [0.79-1.34],0.8417660402467124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other neurological diseases,23692,105,0.85 [0.72-1.01],0.0683851893155284
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23657,272,1.01 [0.90-1.13],0.8416295620277036
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23530,145,1.03 [0.89-1.21],0.6673305402846166
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23463,78,1.01 [0.82-1.25],0.9144610175889124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23471,86,0.98 [0.80-1.19],0.8307865148623715
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23428,43,1.11 [0.83-1.48],0.4839190135021298
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22556,52,1.01 [0.78-1.31],0.9280040713077464
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22666,162,0.97 [0.84-1.12],0.6684065354327046
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23530,106,1.02 [0.85-1.22],0.8619835624367048
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23848,18,1.05 [0.68-1.62],0.8375464651869109
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1527,18,0.99 [0.65-1.51],0.9745118794033824
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22339,18,1.05 [0.68-1.63],0.8119892503600025
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23739,43,1.05 [0.79-1.39],0.7302699873915782
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23719,23,0.92 [0.63-1.34],0.65313689767254
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23648,81,0.87 [0.71-1.06],0.1675423279637143
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23706,88,1.03 [0.85-1.26],0.7548846629719325
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23952,112,0.96 [0.81-1.15],0.6763030691243247
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23599,83,1.12 [0.91-1.38],0.2714940153044816
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18784,1714,1.03 [0.98-1.09],0.1757490714863014
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23797,36,0.72 [0.54-0.96],0.026162328958252
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, essential",19703,1153,1.06 [1.00-1.12],0.0714168748535585
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertension,19720,1170,1.05 [0.99-1.11],0.1057301152565214
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18583,33,0.82 [0.60-1.12],0.209810913174726
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22771,496,0.96 [0.89-1.05],0.3877322215061238
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Angina pectoris,22575,300,0.96 [0.86-1.07],0.4598891865533501
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23444,117,0.96 [0.81-1.14],0.6304834860360391
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23551,224,0.92 [0.82-1.04],0.1843881120092557
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23970,50,0.86 [0.67-1.10],0.2316694376872996
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22415,140,0.94 [0.81-1.10],0.4419412157398324
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22638,372,0.96 [0.87-1.06],0.4004437772283877
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Pulmonary embolism,23615,73,1.01 [0.81-1.25],0.9527398313123052
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Venous thromboembolism,23621,154,0.97 [0.84-1.13],0.7374757030024426
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Secondary right heart disease,23602,60,1.06 [0.83-1.35],0.6407875634765368
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23603,61,1.07 [0.84-1.35],0.595535936755015
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18607,57,1.07 [0.83-1.37],0.6139767475576818
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiomyopathy,21776,40,0.83 [0.63-1.10],0.1876749396079583
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Conduction disorders,21800,64,1.02 [0.81-1.28],0.8727728052359846
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16378,79,1.11 [0.90-1.38],0.3234506079597413
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16467,168,1.03 [0.89-1.19],0.6601509031241064
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arrhythmias,21773,37,1.26 [0.92-1.73],0.1536982306723525
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21788,52,0.78 [0.61-1.00],0.0459047347636217
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Heart failure, strict",23620,108,0.99 [0.83-1.18],0.9089028225280308
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23595,95,0.97 [0.80-1.17],0.7135383909698274
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23626,70,1.02 [0.82-1.27],0.8612034597794462
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23668,61,1.00 [0.79-1.27],0.9938612090404844
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23407,44,0.89 [0.68-1.16],0.3883761673448063
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23438,75,0.92 [0.75-1.13],0.4376622890695534
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23014,101,1.03 [0.85-1.23],0.7887351360637244
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,DVT of lower extremities,22997,84,1.04 [0.85-1.28],0.6898296997575923
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23924,81,1.06 [0.86-1.30],0.5985795154481502
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Varicose veins,23289,376,0.86 [0.79-0.95],0.0022229666731281
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypotension,23430,44,1.01 [0.76-1.33],0.9604504864246522
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20345,1696,1.03 [0.98-1.08],0.2177246429531351
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23867,119,1.02 [0.86-1.20],0.8575299941754015
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Influenza and pneumonia,23019,164,1.02 [0.88-1.18],0.7916618436138764
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22994,139,1.02 [0.87-1.20],0.7934284550035788
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23517,193,0.94 [0.82-1.07],0.339799212102109
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23516,192,0.94 [0.82-1.07],0.3205855097078008
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23289,574,1.07 [0.99-1.16],0.0761681596650281
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic sinusitis,22804,89,1.19 [0.97-1.46],0.08650064048799
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Nasal polyp,22810,95,1.12 [0.92-1.36],0.2538847644913242
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23085,370,1.08 [0.98-1.20],0.1034202659069378
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Deviated nasal septum,22911,196,1.11 [0.97-1.27],0.1269666425281185
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13801,43,1.07 [0.80-1.42],0.6628322265800571
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22010,773,1.00 [0.93-1.06],0.8917287781046414
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Early onset COPD,23440,92,0.96 [0.79-1.16],0.6517393716451794
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23440,92,0.96 [0.79-1.16],0.6517393716451794
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23440,92,0.96 [0.79-1.16],0.6517393716451794
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22526,699,0.99 [0.92-1.06],0.7490708101057391
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Asthma,18369,699,0.99 [0.92-1.07],0.8381150459818497
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18238,699,0.99 [0.92-1.07],0.8272934634128131
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18354,684,0.99 [0.92-1.06],0.7929665546700019
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23897,57,0.97 [0.76-1.23],0.7755463814005488
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Interstitial lung disease,22895,43,0.87 [0.67-1.15],0.3279582154140904
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23955,43,0.88 [0.67-1.15],0.3347288738902868
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22889,37,0.82 [0.61-1.09],0.171039159632764
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural effusion,22887,68,1.12 [0.89-1.40],0.3348843600695939
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of pleura,22974,155,1.06 [0.91-1.23],0.4761997142384986
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23325,70,1.10 [0.88-1.37],0.4218932443941282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17104,4496,1.02 [0.99-1.06],0.1954387223729132
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23542,427,1.02 [0.93-1.11],0.6846793358776155
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24004,116,0.97 [0.82-1.15],0.7366190869916265
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impacted teeth,24009,106,0.98 [0.82-1.17],0.7952881639139364
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Dental caries,23217,102,1.04 [0.86-1.25],0.6840768205420737
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23213,98,1.06 [0.88-1.27],0.5658743017510076
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23991,131,1.00 [0.85-1.17],0.9988325911382108
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23194,79,1.11 [0.90-1.37],0.3455803757141957
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22979,55,0.90 [0.71-1.15],0.4209878954317627
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23960,41,0.81 [0.62-1.07],0.1377108126663784
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19345,185,0.93 [0.82-1.07],0.3134042632119527
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20698,1538,0.99 [0.95-1.04],0.7677305904188355
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophagitis,19394,234,1.06 [0.94-1.20],0.3325187421570377
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19654,494,0.99 [0.91-1.08],0.8220179572429632
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19220,60,1.04 [0.82-1.32],0.7471426766747408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19286,126,1.07 [0.91-1.26],0.4301595827192528
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophageal obstruction,19186,26,1.17 [0.80-1.69],0.4215019382091761
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastric ulcer,19253,93,0.94 [0.78-1.13],0.5197331178196953
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Duodenal ulcer,19254,94,0.88 [0.73-1.05],0.1588918985160583
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23977,66,0.87 [0.70-1.09],0.2192605723924172
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic gastritis,19256,96,0.97 [0.80-1.17],0.7442343315890054
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19724,564,1.00 [0.93-1.09],0.9346844301917544
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of appendix,23907,140,1.01 [0.86-1.18],0.930674115371695
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Functional dyspepsia,19495,335,1.00 [0.90-1.10],0.9289640172056346
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19259,99,0.88 [0.73-1.05],0.1611354985507823
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23896,168,1.02 [0.88-1.17],0.8278529957729539
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute appendicitis,23878,111,1.00 [0.84-1.19],0.9603709777292572
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Hernia,21697,1045,1.02 [0.96-1.08],0.5155997232765314
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Inguinal hernia,20999,347,1.04 [0.95-1.16],0.3912514170608553
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Umbilical hernia,20753,101,0.98 [0.81-1.17],0.8003468756325589
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ventral hernia,20733,81,0.87 [0.71-1.06],0.1547637111978727
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21193,541,1.04 [0.96-1.12],0.3844565749499201
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23307,655,1.13 [1.05-1.22],0.0010384622169586
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestines,19809,1461,1.00 [0.95-1.05],0.9709317016504442
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23777,63,1.07 [0.85-1.35],0.5755111196513537
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23992,89,1.16 [0.95-1.41],0.1584100518289178
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn disease,22741,89,1.16 [0.95-1.42],0.1387477410687483
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn's disease NAS,22721,69,1.24 [0.99-1.57],0.0648847569764101
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23946,113,1.10 [0.92-1.31],0.3072103233759488
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcerative colitis,22765,113,1.10 [0.92-1.31],0.2787536115849049
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22748,96,1.09 [0.90-1.32],0.3670965744379718
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23180,528,1.14 [1.05-1.24],0.0015864234131377
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23176,524,1.14 [1.05-1.24],0.0016657007027805
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18407,59,1.09 [0.85-1.39],0.4919041145458388
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal stricture,23764,59,1.08 [0.85-1.38],0.5206847472306805
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18389,41,1.08 [0.81-1.45],0.599678984271311
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18620,272,1.03 [0.92-1.15],0.6661446795789836
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18497,149,1.00 [0.86-1.16],0.9938333334236374
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18566,218,1.10 [0.96-1.24],0.1623619453701119
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Constipation,23057,193,1.07 [0.94-1.23],0.2976237230860505
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of peritoneum,23683,72,1.03 [0.83-1.27],0.819179964902653
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18505,157,1.05 [0.90-1.22],0.5248171579407483
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18429,81,0.98 [0.80-1.20],0.8502158272605246
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19043,695,0.99 [0.92-1.06],0.7304532397108963
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestine,18506,158,0.82 [0.71-0.95],0.0082917819025989
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23672,61,1.06 [0.83-1.34],0.6528978355211917
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of liver,23424,105,0.70 [0.60-0.83],3.093293963875194e-05
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of liver,23379,60,0.73 [0.59-0.91],0.0057851045447791
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22959,451,0.98 [0.90-1.07],0.7135170169507119
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholelithiasis,22868,360,0.97 [0.88-1.07],0.5688207403580323
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholecystitis,22575,67,1.11 [0.88-1.40],0.3760819739413993
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22545,37,1.01 [0.74-1.38],0.9387056328375204
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute pancreatitis,22557,49,0.76 [0.60-0.98],0.0326225319420935
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23909,49,0.76 [0.60-0.98],0.0314205167822098
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of the digestive system,22975,246,1.08 [0.96-1.21],0.2251168082349951
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal malabsorption,22786,57,1.07 [0.84-1.37],0.5768434186935892
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Coeliac disease,22776,47,1.04 [0.79-1.37],0.7662261514945021
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22767,38,1.18 [0.87-1.61],0.2868895031684008
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22884,155,1.09 [0.94-1.26],0.2778639178068959
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,GI-bleeding,22879,150,1.07 [0.92-1.24],0.3949396618618107
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21827,1291,0.97 [0.92-1.03],0.3050261707948585
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23733,91,0.95 [0.78-1.15],0.5885192141767933
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23701,404,1.00 [0.91-1.09],0.9497281367553052
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23098,454,0.97 [0.89-1.06],0.4561325101650377
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23378,355,0.98 [0.89-1.08],0.7348226063630643
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23116,93,0.89 [0.74-1.07],0.2116590187008091
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23225,202,1.00 [0.88-1.14],0.9944886812222412
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23842,73,0.88 [0.71-1.08],0.2248648750050874
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23830,61,0.94 [0.74-1.18],0.5928851587244074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23814,45,0.96 [0.73-1.25],0.7420932266844076
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23927,27,0.93 [0.66-1.32],0.6943306864084522
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23924,24,0.95 [0.65-1.37],0.7672188744314441
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23355,58,1.20 [0.93-1.54],0.1569099420729642
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23602,305,0.99 [0.89-1.10],0.80541337167181
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22706,62,0.99 [0.78-1.25],0.9289545111529176
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22729,85,0.86 [0.70-1.04],0.1166291096513717
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22717,73,0.87 [0.70-1.07],0.1873267976307054
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22819,175,0.96 [0.83-1.10],0.5526272907751009
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22798,154,0.89 [0.77-1.03],0.1267254277391284
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18614,3056,0.98 [0.94-1.01],0.2207193552924455
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20006,1635,0.97 [0.93-1.02],0.2527176025092768
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21927,951,1.06 [1.00-1.13],0.0635210007526477
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18483,112,1.01 [0.85-1.21],0.8801574694111214
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18677,306,0.94 [0.84-1.04],0.2163140486538439
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23769,107,1.03 [0.86-1.23],0.757321068889995
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23781,95,0.99 [0.82-1.20],0.9389976424153204
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18946,575,1.00 [0.92-1.08],0.986396865964617
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",21200,575,1.00 [0.93-1.09],0.915681566007298
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18410,39,1.10 [0.81-1.48],0.5492518953193188
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23732,38,1.09 [0.81-1.48],0.5642621351246102
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18503,132,0.85 [0.73-1.00],0.0434659536066602
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18393,22,1.03 [0.69-1.54],0.8806482214088068
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18481,110,0.98 [0.82-1.16],0.790190683864221
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23962,55,1.03 [0.81-1.32],0.7974573024421134
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18661,290,1.03 [0.92-1.15],0.6242016432239346
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18562,191,0.97 [0.85-1.11],0.6854215893274342
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19454,1083,0.97 [0.91-1.02],0.2303564866504962
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18409,38,1.14 [0.84-1.55],0.3991474066393341
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18525,154,0.92 [0.79-1.06],0.2427106820090873
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18396,25,1.15 [0.78-1.67],0.4837453007785572
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18397,26,1.10 [0.76-1.60],0.6026652278188962
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18817,446,0.98 [0.90-1.08],0.7338600990328834
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18743,372,0.99 [0.90-1.09],0.8461997745460345
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18992,246,0.96 [0.85-1.08],0.508693514447284
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23708,142,0.85 [0.73-0.99],0.0330669051787243
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23603,37,0.83 [0.62-1.11],0.2181457529461724
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21476,45,0.96 [0.73-1.27],0.7810068690001328
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21626,195,0.88 [0.77-1.00],0.0441688822968042
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22229,798,0.93 [0.87-1.00],0.0437005100273066
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21552,121,0.98 [0.83-1.16],0.8096492477047466
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21480,49,0.72 [0.57-0.92],0.0093179995404779
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22103,672,0.94 [0.88-1.01],0.1025639330348996
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21480,49,0.94 [0.72-1.21],0.609456029330119
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21663,232,0.95 [0.85-1.08],0.4547785245645613
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21534,103,0.99 [0.83-1.19],0.9269544344887838
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21489,58,1.03 [0.81-1.32],0.7983489338218953
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21554,123,0.89 [0.76-1.05],0.1665332770659355
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21490,59,1.02 [0.80-1.30],0.86504998320251
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21717,286,1.02 [0.91-1.14],0.7530288584921552
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21218,242,1.03 [0.91-1.16],0.6509226889673574
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21025,49,0.98 [0.76-1.27],0.8988638841311373
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21017,41,0.95 [0.72-1.27],0.7405212243102579
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21076,100,1.12 [0.93-1.35],0.2380766200214256
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21028,52,1.03 [0.80-1.34],0.8186978808138052
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21029,53,1.16 [0.89-1.51],0.2708037187795846
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21015,39,1.07 [0.79-1.45],0.653203621402686
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21162,186,1.00 [0.87-1.14],0.9470469838606104
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21023,47,0.97 [0.74-1.27],0.8150685907836875
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21019,43,1.06 [0.80-1.41],0.6950490132475445
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21068,92,0.99 [0.81-1.20],0.8896399913834855
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21039,63,0.93 [0.74-1.17],0.521753654632115
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21359,383,1.10 [1.00-1.21],0.0627674467154136
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21109,133,1.02 [0.87-1.19],0.8349351577761539
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21173,197,1.16 [1.02-1.33],0.0296490324006515
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22841,91,0.89 [0.74-1.08],0.2510534724817713
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23043,293,0.91 [0.82-1.01],0.0708580817781666
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22799,49,0.98 [0.76-1.27],0.8752262024898522
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22806,56,0.96 [0.75-1.23],0.7565270668327846
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22850,100,0.90 [0.76-1.08],0.2763673519408626
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20381,3794,0.98 [0.95-1.01],0.2205389818103926
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9766,347,1.00 [0.90-1.11],0.9828789229906572
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22759,164,0.91 [0.79-1.05],0.1928836531121504
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22642,47,1.01 [0.77-1.32],0.9522352729534962
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Acute renal failure,22898,32,0.66 [0.49-0.89],0.0066114505494412
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22898,32,0.89 [0.65-1.22],0.4863826207824202
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22906,40,0.90 [0.68-1.20],0.4652570981509379
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urolithiasis,23746,201,1.06 [0.93-1.21],0.3863805703525145
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23809,48,1.11 [0.84-1.46],0.4626630800854444
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23686,141,1.01 [0.87-1.19],0.8570536611365398
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23627,82,1.20 [0.97-1.49],0.0890381879053256
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22755,767,0.95 [0.89-1.02],0.1518467805546735
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cystitis,22059,71,0.83 [0.67-1.03],0.0882343093278945
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22045,57,1.11 [0.86-1.42],0.4233339447858389
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22143,155,0.99 [0.85-1.14],0.8532772918008864
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urethral stricture,22068,80,0.91 [0.75-1.12],0.3882293424009104
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22528,540,0.98 [0.90-1.06],0.5449632262335924
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9478,59,1.17 [0.91-1.50],0.2148613408459105
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9452,33,0.86 [0.63-1.18],0.3570209259059245
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hydrocele,9454,35,0.89 [0.66-1.21],0.4745854485674314
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9491,72,1.01 [0.81-1.26],0.9229804332917412
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9475,56,1.10 [0.85-1.41],0.4782386891474092
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9501,82,0.89 [0.73-1.09],0.2527186006422327
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Disorders of breast,13149,218,1.01 [0.89-1.15],0.8525908640852524
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12997,66,1.05 [0.83-1.32],0.6969940475390615
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,13004,73,1.07 [0.86-1.33],0.5528183857833584
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12978,47,0.90 [0.69-1.16],0.4153159937530279
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13116,340,1.03 [0.93-1.14],0.584039232989091
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,12847,71,1.06 [0.85-1.32],0.6223581719419602
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12946,170,1.05 [0.91-1.21],0.5452224060994946
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12100,2392,1.00 [0.96-1.05],0.8354474447266025
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Endometriosis,9956,248,1.09 [0.97-1.24],0.1446093124407687
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9785,77,1.28 [1.03-1.61],0.0293467670592559
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9807,99,1.05 [0.87-1.27],0.6145370824449217
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9973,265,1.08 [0.96-1.21],0.2112009633522008
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9975,267,0.91 [0.82-1.02],0.1178835166782512
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10126,418,0.98 [0.90-1.08],0.7020485843909585
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Uterine polyps,9856,148,0.97 [0.84-1.13],0.7022384021225658
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9897,189,1.06 [0.92-1.21],0.440209309319525
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9781,73,1.16 [0.92-1.45],0.202296575936797
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9837,129,1.10 [0.93-1.30],0.2584379021940287
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13277,175,1.14 [0.98-1.31],0.0852782000905239
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13286,168,1.14 [0.98-1.32],0.0902872323352942
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13302,94,1.22 [1.00-1.49],0.0531755556708346
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13294,102,1.21 [1.00-1.47],0.0512752660721766
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9768,60,0.86 [0.68-1.08],0.1938004716745528
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9762,54,0.97 [0.76-1.25],0.836506171367134
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9770,62,0.79 [0.63-0.98],0.0339692656583427
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Irregular menses,13216,319,1.12 [1.01-1.25],0.0366497665304766
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10696,988,1.04 [0.97-1.10],0.2690578551857037
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Menorrhagia,10391,683,1.01 [0.94-1.08],0.8627334767209591
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13289,138,1.00 [0.86-1.17],0.9988894182694308
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,10012,304,0.98 [0.88-1.09],0.6566052909560405
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9937,229,0.94 [0.83-1.06],0.3249663127411767
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9930,222,1.00 [0.88-1.13],0.9640001673388318
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Female infertility,9791,83,1.11 [0.89-1.38],0.3470950143971083
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9784,76,1.08 [0.86-1.35],0.5063048866246774
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13294,720,1.00 [0.93-1.08],0.9597417004477242
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13301,987,1.03 [0.96-1.11],0.3517194636137175
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13295,379,1.14 [1.03-1.26],0.0132480723083053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,13023,107,1.16 [0.96-1.40],0.1294053211511038
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,13063,147,1.03 [0.88-1.21],0.6949424400427396
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,13053,137,1.30 [1.09-1.54],0.0031543806817131
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13311,142,0.97 [0.83-1.13],0.682248391085176
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13313,139,0.97 [0.83-1.14],0.7405745958602074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13311,352,0.91 [0.82-1.01],0.0882826829610436
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,13063,104,0.81 [0.68-0.97],0.0224407914604997
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13155,196,0.94 [0.82-1.08],0.3595581461353916
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12697,123,1.07 [0.89-1.27],0.4716787291094082
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12740,166,1.01 [0.87-1.18],0.8540776817078342
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12775,201,0.99 [0.86-1.13],0.8368108215707027
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12696,122,0.99 [0.83-1.17],0.8680987841557705
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",False labour,12686,112,1.09 [0.91-1.31],0.3635882338055834
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12700,126,0.87 [0.74-1.03],0.1103618567463442
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12498,184,1.09 [0.94-1.25],0.2604306233515447
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12679,365,1.02 [0.92-1.13],0.7391093370602466
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,12862,548,1.08 [0.99-1.18],0.079246511909111
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13316,144,1.04 [0.88-1.22],0.6598373305982541
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,12120,110,1.02 [0.85-1.22],0.8106577013319648
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12398,84,1.01 [0.82-1.25],0.907818604983478
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13321,279,0.93 [0.83-1.05],0.2489385519532334
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13258,216,0.93 [0.81-1.06],0.262422522793226
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13310,214,1.06 [0.93-1.21],0.3804994590429982
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13300,204,1.06 [0.92-1.21],0.4358987252590329
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23848,31,0.99 [0.71-1.37],0.9297529317319696
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Falls/tendency to fall,22624,440,0.87 [0.80-0.95],0.0017075322453943
